Resmetirom offers a targeted approach to metabolic dysfunction–associated steatohepatitis (MASH) for use alongside lifestyle ...

Non-Alcoholic Steatohepatitis (NASH): Fatty liver with inflammation and damage, which may progress to cirrhosis and liver cancer. Worldwide, 1 billion people are affected. In India, 18-20% of the ...

Shares in the company lost around 16% of their value after the top-line result of the REVERSE study in patients with compensated NASH-related cirrhosis were announced, as investors tried to work ...

One of these is non-alcoholic steatohepatitis, or NASH, the fatty liver disease that affects millions of people and which is poised to be one of pharma’s next big growth areas. Novartis ramped ...

Nonalcoholic steatohepatitis (NASH) is the progressive form of liver injury that carries a risk for progressive fibrosis, cirrhosis, and end-stage liver disease. Hepatocellular carcinoma (HCC ...

Background: It is currently recommended that all patients with liver cirrhosis undergo upper gastrointestinal endoscopy (UGIE) to identify those who have large esophageal varices (LEVx ...

A new study sheds light on changes to the fetus's bile acid, which affects how liver disease develops and ... Mar. 7, 2025 — High levels of ammonia kill liver cells by damaging the mitochondria ...

Mar 25 | The husband-and-wife team is bringing an all-day cafe concept to Germantown. Mar 24 | The company has ended a grant from the state to add hundreds of jobs, after enduring a few years of ...

This is especially the case if you have liver damage (cirrhosis). Unfortunately, people with severe liver damage may be too unwell to have treatment for their cancer. Your doctor can use different ...

Introduction A quality improvement project was carried out at a district general hospital focusing on the clinical management of patients presenting with decompensated liver cirrhosis. Method A ...